Nu Skin Enterprises, Inc.
NUS
NYSE
9.98
USD+0.17(+1.73%)
As of today
Nu Skin Enterprises, Inc. fundamentals
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 2,581,934,000 | 2,695,669,000 | 2,225,659,000 | 1,969,131,000 | 1,732,084,000 | |
| Gross Profit | 1,923,906,000 | 2,020,446,000 | 1,594,744,000 | 1,357,281,000 | 1,181,851,000 | |
| Operating Income | 257,564,000 | 233,992,000 | 110,847,000 | 48,268,000 | -151,585,000 | |
| Net Income | 191,355,000 | 147,266,000 | 104,778,000 | 8,595,000 | -146,594,000 | |
| Total Assets | 1,957,076,000 | 1,906,480,000 | 1,820,970,000 | 1,806,463,000 | 1,468,914,000 | |
| Total Current Liabilities | 542,856,000 | 529,694,000 | 359,243,000 | 328,871,000 | 296,607,000 | |
| Total Equity | 894,271,000 | 912,772,000 | 897,296,000 | 821,968,000 | 651,455,000 | |
| Free Cash Flow | 315,318,000 | 72,967,000 | 49,006,000 | 60,149,000 | 70,159,000 | |
| Cash from Operations | 379,141,000 | 141,582,000 | 108,062,000 | 118,639,000 | 111,742,000 | |
| Cash from Investing | -79,428,000 | -88,726,000 | -67,079,000 | -134,501,000 | -37,962,000 | |
| Cash from Financing | -245,166,000 | -104,702,000 | -99,504,000 | 10,730,000 | -133,176,000 | |
| Net Change in Cash | 67,053,000 | -63,090,000 | -74,868,000 | -8,668,000 | -69,174,000 |